Ethyl 5-oxooxolane-2-carboxylate
Common Name: |
Ethyl 5-oxooxolane-2-carboxylate |
IUPAC Name: |
ethyl 5-oxooxolane-2-carboxylate |
Molecular Formula: |
C16H14O2 |
SMILES: |
CCOC(=O)C1CCC(=O)O1 |
Inchi: |
1S/C7H10O4/c1-2-10-7(9)5-3-4-6(8)11-5/h5H,2-4H2,1H3 |
Inchi Key: |
MJQGWRVDIFBMNW-UHFFFAOYSA-N |
Cas No: |
1126-51-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
238.28 |
Mass (g/mol) |
158.058 |
Molar Refractivity |
72.14 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
5 |
Rings |
1 |
TPSA |
26.30 |
Hetero Atoms |
4 |
Heavy Atoms |
18 |
Aromatic Heavy Atoms |
12 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.06 |
LogP |
0.255 |
iLOGP |
3.07 |
XLOGP3 |
4.61 |
WLOGP |
3.45 |
MLOGP |
3.84 |
ESOL Log S |
-4.38 |
ESOL Solubility (mg/ml) |
0.01 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-4.89 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-5.11 |
Silicos-IT Solubility (mg/ml) |
0 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.48 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.486 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
1 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.051 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |